IMPORTANT - EIN Presswire is proud to announce the launch of its AI-powered press release generator. Try it now!

IMPORTANT - EIN Presswire is proud to announce the launch of its AI-powered press release generator. Try it now!

World Media Directory · RSS · Email Newsletters

There were 1,541 press releases posted in the last 24 hours and 392,927 in the last 365 days.

Technology Press Releases

Technology Press Releases Distributed by EIN Presswire

323,322 Press Releases · RSS · Email

Published on May 28, 2024 - 12:15 GMT

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and ...

-- Greek Ministry of Health approved VAZKEPA® (icosapent ethyl) for national reimbursement to reduce cardiovascular risk in statin-treated adult patients with elevated triglycerides (≥ 150 mg/ml [≥ 1.7 mmol/l) and other high-risk characteristics as studied …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 28, 2024 - 12:05 GMT

Longeveron® to Attend BIO International Convention 2024

MIAMI, May 28, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that the Company …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 28, 2024 - 12:01 GMT

Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting

Key Findings: 92.3% Sensitivity for Colorectal Cancer, 82.3% for Advanced Precancerous Lesions Poster presentation showing new data on 690 subjects including previously unexamined and unreported samples from the pooled ColoFuture and eAArly DETECT studies …

Distribution channels: Culture, Society & Lifestyle, Technology ...
Published on May 28, 2024 - 12:00 GMT

Spectral AI to Participate in Benzinga’s “AI Unleashed: Exploring the Possibilities” Virtual Event

DALLAS, May 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today …

Distribution channels: Culture, Society & Lifestyle, Technology ...
Published on May 28, 2024 - 12:00 GMT

Aummune’s Poster at ASCO 2024 to Highlight Ongoing Phase 1 Trial for AM003

AM003 is a first-in-class functional oligonucleotide in development for the treatment of solid tumors Trial-in-Progress poster to provide an overview of the Phase 1 dose-escalation study with AM003 in patients with advanced disease TEL AVIV, Israel, May 28 …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 28, 2024 - 12:00 GMT

Lantheus to Present at the William Blair 44th Annual Growth Stock Conference

BEDFORD, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, …

Distribution channels:
Published on May 28, 2024 - 12:00 GMT

Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference

SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for the potential treatment of neurological disorders, today announced that Cory R. Nicholas, Ph …

Distribution channels:
Published on May 28, 2024 - 12:00 GMT

Foresight Announces First Quarter 2024 Financial Results

NESS ZIONA, Israel, May 28, 2024 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, today reported financial results for the first quarter of 2024. Key …

Distribution channels:
Published on May 28, 2024 - 12:00 GMT

Gorilla Technology and SINTRONES Partner to Develop In-Vehicle AI Computing Capabilities

LONDON, May 28, 2024 (GLOBE NEWSWIRE) -- Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the “Company”), a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence and IoT technology, today …

Distribution channels:
Published on May 28, 2024 - 12:00 GMT

Tide Capital Receives Investment from GoFintech Innovation, a Hong Kong-listed Securities Firm, to Develop Compliant Digital Asset ...

HONG KONG , May 28, 2024 (GLOBE NEWSWIRE) -- In May 2024, Tide Capital's hedge fund secured investment from a subsidiary of GoFintech Innovation Limited (00290.HK), a Hong Kong-listed full-licensed financial corporation. GoFintech Innovation operates …

Distribution channels: Technology ...
Published on May 28, 2024 - 12:00 GMT

Reviva Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

CUPERTINO, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …

Distribution channels: Technology ...
Published on May 28, 2024 - 12:00 GMT

ceτi AI Receives $2 Million Worth of H100 GPUs at T3 Data Center

Vancouver, BC, Canada, May 28, 2024 (GLOBE NEWSWIRE) -- ceτi AI, a pioneering company building decentralized AI infrastructure, announced it received $2 million worth of cutting-edge hardware at its T3 Data Center in Vancouver, British Columbia. The event …

Distribution channels: Technology ...
Published on May 28, 2024 - 11:45 GMT

NeuralAI Launches AI 3D Asset Generator with TAO Bittensor Subnet: Transforming 3D Model Creation for Games and Beyond

Silicon Oasis, Dubai UAE, May 28, 2024 (GLOBE NEWSWIRE) -- NeuralAI is thrilled to announce the launch of its groundbreaking AI-based 3D game asset generator, designed to revolutionize the way 3D models are produced. NeuralAI leverages advanced generative …

Distribution channels: Technology ...
Published on May 28, 2024 - 11:35 GMT

Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights ...

J&J will gain full rights to develop, manufacture and commercialize NM26 globally for the treatment of atopic dermatitis and follow-on indications Under the agreement terms, J&J will pay $1.25 billion to acquire Yellow Jersey Therapeutics, which …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 28, 2024 - 11:30 GMT

Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference

CLEVELAND, May 28, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its senior management team will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 11 …

Distribution channels:
Published on May 28, 2024 - 11:30 GMT

Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD

SAN FRANCISCO and WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary …

Distribution channels: Companies, Technology ...
Published on May 28, 2024 - 11:30 GMT

TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 ...

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming presentations highlighting study designs for post-marketing studies being undertaken for BRIUMVI® (ublituximab-xiiy) in patients with …

Distribution channels: Media, Advertising & PR, Technology ...
Published on May 28, 2024 - 11:30 GMT

Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD

Phase 3 program enrolled 1,984 patients across COAST and ShORe trials Trials designed to replicate superiority in visual outcomes demonstrated in Phase 2b Topline data from both pivotal trials expected in mid-CY2025 MELBOURNE, Australia and PRINCETON, N.J …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 28, 2024 - 11:30 GMT

Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase ...

WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today …

Distribution channels: Banking, Finance & Investment Industry, Technology ...
Published on May 28, 2024 - 11:21 GMT

How Bitcoin (BTC)’s Regulation, Ethereum (ETH)’s Updates, and Furrever Token’s Launch Could Transform the Market

New York City, NY, May 28, 2024 (GLOBE NEWSWIRE) -- The cryptocurrency market is in a constant state of flux, driven by regulatory changes, technological advancements, and the introduction of new players. Currently, Bitcoin, Ethereum, and Furrever Token …

Distribution channels: Technology ...

Previous 6 7 8 9 10 11 12 13 14 15 16 Next